{
    "clinical_study": {
        "@rank": "63880", 
        "arm_group": [
            {
                "arm_group_label": "Self adhesive foam dressing", 
                "arm_group_type": "Experimental", 
                "description": "Sponsor manufactured self adhesive foam dressing. Use of CE marked dressing according to instructions for use and study protocol."
            }, 
            {
                "arm_group_label": "Comparator self adhesive foam dressing", 
                "arm_group_type": "Active Comparator", 
                "description": "Non Sponsor manufactured self adhesive foam dressing. Use of CE marked dressing according to instructions for use and study protocol."
            }
        ], 
        "brief_summary": {
            "textblock": "ALLEVYN\u25ca Life and Mepilex\u2122 Border are both layered foam dressings with a silicone adhesive\n      wound contact layer.  Both are indicated for the same uses; however ALLEVYN\u25ca Life has a\n      number of attributes designed to meet a range of characteristics associated with principles\n      of wellbeing.\n\n      The aim for this evaluation is to assess, in a clinical setting and against a number of\n      identified criteria, the performance of the ALLEVYN\u25ca Life dressing compared to Mepilex\u2122\n      Border in terms of characteristics of the attributes of wellbeing.\n\n      \u25ca Trademark of Smith & Nephew\n\n      \u2122 All trademarks acknowledged"
        }, 
        "brief_title": "A RCT to Compare Performance of Two Foam Dressings on Patient Well-being Related Endpoints.", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Wounds", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients \u226518 years old\n\n        Males and females (females must not be pregnant and must use contraception if of child\n        bearing potential.)\n\n        Presence of a single suitable wound which can be the reference wound without treatment\n        impacting on any other wound(s) on the patient.\n\n        Presence of a suitable wound which can be treated with the available sizes and shapes of\n        ALLEVYN\u25ca Life (10.3cm X 10.3cm, 12.9cm X 12.9cm, 15.4cm X 15.4cm, 21cm X 21cm) and\n        Mepilex\u2122  Border (7cm X 7.5cm, 10cm X 12.5cm, 15cm  X 17.5, 17cm X 20cm)\n\n        Presence of an exuding wound of at least 6 weeks duration at the point of enrolment,\n        healing by secondary intention\n\n        The patient is able to understand the evaluation and is willing to consent to the\n        evaluation.\n\n        The patient is available to participate for the anticipated duration of the evaluation.\n\n        Exclusion Criteria:\n\n        Patients with confirmed or suspected clinically infected reference wounds.\n\n        Patients with wounds that, in the opinion of the clinician, is likely to heal within a\n        time period of 4 weeks from point of enrolment.\n\n        Patients with a reference wound undergoing treatment with compression therapy.\n\n        Patients where a reference wound cannot be treated in isolation from other wounds.\n\n        Patients with deep reference wounds that, in the opinion of the clinician, necessitate\n        filler material.\n\n        Patients with a known sensitivity to any of the constituents of the evaluation products.\n\n        Patients with a known history of poor compliance with medical treatment.\n\n        Patients who have participated in this evaluation previously and have been withdrawn from\n        the study.\n\n        Patients unable to understand or speak the English language.\n\n        Patients without the capacity to understand and answer wellbeing related questions\n\n        Females who are pregnant or breast feeding."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02053337", 
            "org_study_id": "CE047ALF"
        }, 
        "intervention": {
            "arm_group_label": [
                "Self adhesive foam dressing", 
                "Comparator self adhesive foam dressing"
            ], 
            "description": "Self adhesive foam dressing", 
            "intervention_name": "Self adhesive foam dressing", 
            "intervention_type": "Device", 
            "other_name": "ALLEVYN\u25ca  Life"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 31, 2014", 
        "number_of_arms": "2", 
        "official_title": "A Randomised Cross-over Clinical Evaluation to Compare Performance of ALLEVYN\u25ca Life and Mepilex\u2122 Border Dressings on Patient Well-being Related Endpoints.", 
        "overall_contact": {
            "email": "jayne.stuart@smith-nephew.com", 
            "last_name": "Jayne EM Stuart", 
            "phone": "01482 673420", 
            "phone_ext": "2420"
        }, 
        "overall_contact_backup": {
            "email": "kate.drysdale@smith-nephew.com", 
            "last_name": "Kate Drysdale", 
            "phone": "01482 673405", 
            "phone_ext": "2405"
        }, 
        "overall_official": {
            "affiliation": "University of Huddersfield", 
            "last_name": "Karen Ousey", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome, a subjective patient wellbeing/preference score, is calculated using a combination of responses from 8 individual questions on a patient questionnaire and 2 further dressing retention related measures at the end of treatment with each dressing (up to maximum of 10 days). Individual patient questions relate to the effect of specific dressing performance /characteristics on patient wellbeing (each on a 0-10 scale: 0 = most negative response, 10 = most positive response).", 
            "measure": "Subjective rating of the impact of the dressing performance and characteristics on patient wellbeing (referred to as patient wellbeing score)", 
            "safety_issue": "No", 
            "time_frame": "After (up to) 10 days of dressing wear"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02053337"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Smith & Nephew Medical Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Smith & Nephew Medical Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}